These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 3485045)

  • 1. Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
    Spiess YH; Price PA; Deftos JL; Manolagas SC
    Endocrinology; 1986 Apr; 118(4):1340-6. PubMed ID: 3485045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
    Theofan G; Price PA
    Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
    Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by retinoic acid of 1,25-dihydroxyvitamin D3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line.
    Grigoriadis AE; Petkovich PM; Rosenthal EE; Heersche JN
    Endocrinology; 1986 Aug; 119(2):932-9. PubMed ID: 3015560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines.
    Fraser JD; Otawara Y; Price PA
    J Biol Chem; 1988 Jan; 263(2):911-6. PubMed ID: 3257212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
    Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
    J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of diastereoisomers of 1,25-dihydroxyvitamin D3-26,23-lactone on alkaline phosphatase and collagen synthesis in osteoblastic cells.
    Ishizuka S; Kiyoki M; Kurihara N; Hakeda Y; Ikeda K; Kumegawa M; Norman AW
    Mol Cell Endocrinol; 1988 Jan; 55(1):77-86. PubMed ID: 2834243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
    Pan LC; Price PA
    J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of 1,25 dihydroxyvitamin d3 on the morphology and alkaline phosphatase activity of ROS 17/2,8 osteoblastic cells: influence of time and dose].
    Chavassieux P; Boivin G; Terrier C; Serre CM; Lagarde D; Meunier PJ
    Reprod Nutr Dev; 1990; 30(3):439-43. PubMed ID: 2397037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.
    Fraser JD; Price PA
    Calcif Tissue Int; 1990 Apr; 46(4):270-9. PubMed ID: 2108798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
    Hale LV; Kemick ML; Wuthier RE
    J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of 1,25-dihydroxyvitamin D3-induced stimulation of alkaline phosphatase in cultured osteoblast-like cells.
    Manolagas SC; Spiess YH; Burton DW; Deftos LJ
    Mol Cell Endocrinol; 1983 Nov; 33(1):27-36. PubMed ID: 6357897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
    J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 1,25-dihydroxyvitamin D3 on cultured osteogenic sarcoma cells: correlation with the 1,25-dihydroxyvitamin D3 receptor.
    Dokoh S; Donaldson CA; Haussler MR
    Cancer Res; 1984 May; 44(5):2103-9. PubMed ID: 6324995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.